| [1] | Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996; 93:841-842. | | [2] | Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al; American heart association; council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; council on epidemiology and prevention. contemporary definitions and classification of the cardiomyopathies: an american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006; 113: 1807-1816. | | [3] | Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008; 29:270-276. | | [4] | Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, et al. The moge(s) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the world heart federation. Glob Heart 2013; 8:355-382. | | [5] | Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 2016; 37:1850-1858. | | [6] | Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 2016; 67:2996-3010. | | [7] | Hazebroek M, Dennert R, Heymans S. Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies. Neth Heart J 2012; 20:332-335. | | [8] | Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015; 36:1090-1097. | | [9] | Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, et al. Dilated cardiomyopathy. Nat Rev Dis Primers 2019; 5: 32. | | [10] | Popescu BA, Beladan CC, Calin A, Muraru D, Deleanu D, Rosca M, et al. Left ventricular remodelling and torsional dynamics in dilated cardiomyopathy: reversed apical rotation as a marker of disease severity. Eur J Heart Fail 2009; 11:945-951. | | [11] | Amorim S, Rodrigues J, Campelo M, Moura B, Martins E, Macedo F, et al. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction. Int J Cardiovasc Imaging 2017; 33:605-613. | | [12] | Levine YC, Matos J, Rosenberg MA, Manning WJ, Josephson ME, Buxton AE. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy. Heart Rhythm 2016; 13:490-497. | | [13] | Melo SA Jr, Macchiavello B, Andrade MM, Carvalho JL, Carvalho HS, Vasconcelos DF, et al. Semi-automatic algorithm for construction of the left ventricular area variation curve over a complete cardiac cycle. Biomed Eng Online 2010; 9: 5. | | [14] | Iida Y, Inomata T, Kaida T, Fujita T, Ikeda Y, Nabeta T, et al. Prognostic impact of segmental wall motion abnormality in patients with idiopathic dilated cardiomyopathy. Int Heart J 2017; 58:544-550. | | [15] | Kamperidis V, van Wijngaarden SE, van Rosendael PJ, Kong WKF, Regeer MV, van der Kley F, et al. Mitral valve repair for secondary mitral regurgitation in non-ischaemic dilated cardiomyopathy is associated with left ventricular reverse remodelling and increase of forward flow. Eur Heart J Cardiovasc Imaging 2018; 19:208-215. | | [16] | Shao L, Zhao BW, Wang B, Peng XH, Chen R, Huang YH, et al. Evaluation of right atrial function in patients with dilated cardiomyopathy and ischemic cardiomyopathy using two-dimensional speckle tracking imaging. Chinese Journal of Ultrasonography 2015, 24: 204-208. | | [17] | Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al; Scientific document committee of the european association of cardiovascular imaging. recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the european association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2013; 14:611-644. | | [18] | Zeng D, Wu J, Wu SS, Lin HH, Chen H. Three-dimensional echocardiographic comparison of left ventricular geometry and systolic function between dilated cardiomyopathy and mitral regurgitation with similar left ventricular dilation. J Clin Ultrasound 2020; 48:29-37. | | [19] | Li F, Chen YG, Yao GH, Li L, Ge ZM, Zhang M, et al. Usefulness of left ventricular conic index measured by real-time three-dimensional echocardiography to predict left ventricular remodeling after acute myocardial infarction. Am J Cardiol 2008; 102:1433-1437. | | [20] | Mei DE, Chen JL, Feng CL, Zhao ZY, Zhu HN. Assessment of left ventricular dyssynchrony and its relationship with cardiac function in dilated cardiomyopathy by two-dimensional strain parameters. Chin J Med Imaging Technol 2017, 33: 1339-1343. | | [21] | Zairi I, Mzoughi K, Jabeur M, Jnifene Z, Ben Moussa F, Kamoun S, et al. Right ventricular systolic echocardiographic parameters in dilated cardiomyopathy and prognosis. Tunis Med 2017; 95:87-91. | | [22] | Dutta T, Aronow WS. Echocardiographic evaluation of the right ventricle: clinical implications. Clin Cardiol 2017; 40:542-548. | | [23] | Amsallem M, Mercier O, Kobayashi Y, Moneghetti K, Haddad F. Forgotten no more: a focused update on the right ventricle in cardiovascular disease. JACC Heart Fail 2018; 6:891-903. | | [24] | Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the european society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 2016; 29:277-314. | | [25] | Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, et al; EACVI Scientific documents committee for 2014-16 and 2016-18; EACVI scientific documents committee for 2014-16 and 2016-18. clinical practice of contrast echocardiography: recommendation by the european association of cardiovascular imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging 2017; 18:1205-1205af. | | [26] | Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al; European association of echocardiography. stress echocardiography expert consensus statement- -executive summary: european association of echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009; 30:278-289. | | [27] | Minoshima M, Noda A, Kobayashi M, Miyata S, Hirashiki A, Okumura T, et al. Endomyocardial radial strain rate imaging during dobutamine stress echocardiography for the evaluation of contractile reserve in patients with dilated cardiomyopathy. J Clin Ultrasound 2016; 44:555-560. | | [28] | Makavos G, Κairis C, Tselegkidi ME, Karamitsos T, Rigopoulos AG, Noutsias M, et al. Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment. Heart Fail Rev 2019; 24:439-459. | | [29] | Song YR, Liu Z, Gu SL, Qian LJ, Yan QF. Advances in the molecular pathogenesis of hypertrophic cardiomyopathy. Hereditas 2011, 33:549-557. | | [30] | Ingles J, Goldstein J, Thaxton C, Caleshu C, Corty EW, Crowley SB, et al. Evaluating the clinical validity of hypertrophic cardiomyopathy genes. Circ Genom Precis Med 2019; 12: e002460. | | [31] | Tang L, Zhou NW, Jiang YY, Li XJ, Sun MM, Pan CZ, et al. A research on the relationship of genotypes and phenotypes in hypertroph,c cardiomyopathy. Chin J Ultrasonogr 2020, 29: 219-223. | | [32] | Song L, Zou YB, Wang DW, Hui RT. Guidelines for the diagnosis and treatment of adult hypertrophic cardiomyopathy in China. Chinese Journal of Cardiology 2017, 45:1015-1032. [In Chinese] | | [33] | Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC). Eur Heart J 2014; 35:2733-2779. | | [34] | Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2016; 17:1191-1229. | | [35] | Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, et al. American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American society of nuclear cardiology, society for cardiovascular magnetic resonance, and society of cardiovascular computed tomography. J Am Soc Echocardiogr 2011; 24:473-498. | | [36] | Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy clinical update. J ACC Heart Fail 2018, 6: 364-375. | | [37] | Zhang Y, Yin LX, Deng YB, Ren WD, Mu YM, Zhang M, et al. Guideline of standardized operation of stress echocardiography. Chinese Journal of Medical Imaging Technology 2017, 33: 632-638. | | [38] | Kitaoka H, Kubo T, Okawa M, Takenaka N, Sakamoto C, Baba Y, et al. Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2011; 24:1020-1025. | | [39] | Bayrak F, Kahveci G, Mutlu B, Sonmez K, Degertekin M. Tissue doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy. Eur J Echocardiogr 2008; 9:278-283. | | [40] | Gilman G, Khandheria BK, Hagen ME, Abraham TP, Seward JB, Belohlavek M. Strain rate and strain: a step-by-step approach to image and data acquisition. J Am Soc Echocardiogr 2004; 17:1011-1020. | | [41] | Zhang XK, Na LS, Liu LW, Zuo L, Li J, Wang B, et al. Three-dimensional speckle tracking technology in evaluating early changes of left ventricular systolic function and synchrony in hypertrophic cardiomyopathy patients with truncating mutations of MYBPC3 gene. Chinese J Ultrasound in Med 2017, 33:228-230. | | [42] | Chen S, Duan F, Yuan J, Qiao S, Lv X, Hu F, et al. Effect of septal ablation on regional diastolic dysfunction and diastolic asynchrony in patients with hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography. Echocardiography 2013; 30:564-571. | | [43] | Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, et al. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2009; 2:314-321. | | [44] | Cortigiani L, Rigo F, Gherardi S, Galderisi M, Sicari R, Picano E. Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy. Am J Cardiol 2008; 102:1718-1723. | | [45] | Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr 2009; 10:194-212. | | [46] | Labombarda F, Pellissier A, Saloux É. Fibrosis suggested by 3D contrast-enhanced echocardiography in hypertrophic cardiomyopathy. Arch Cardiovasc Dis 2011; 104:680-681. | | [47] | Tajima M, Iguchi N, Utanohara Y, Hiroi Y, Mahara K, Niwa T, et al. Computed tomography imaging to quantify the area of the endocardial subvalvular apparatus in hypertrophic cardiomyopathy - Relationship to outflow tract obstruction and symptoms. J Cardiovasc Comput Tomogr 2016; 10:351-358. | | [48] | Kubo T, Kitaoka H. Imaging of left ventricular hypertrophy: a practical utility for differential diagnosis and assessment of disease severity. Curr Cardiol Rep 2017; 19: 65. | | [49] | Hong JA, Kim MS, Cho MS, Choi HI, Kang DH, Lee SE, et al. Clinical features of idiopathic restrictive cardiomyopathy: a retrospective multicenter cohort study over 2 decades. Medicine (Baltimore) 2017; 96: e7886. | | [50] | Hayashi T, Tsuda E, Kurosaki K, Ueda H, Yamada O, Echigo S. Electrocardiographic and clinical characteristics of idiopathic restrictive cardiomyopathy in children. Circ J 2007; 71:1534-1539. | | [51] | Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 2016; 29:277-314. | | [52] | Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, et al. Multimodality imaging in restrictive cardiomyopathies: an eacvi expert consensus document in collaboration with the "working group on myocardial and pericardial diseases" of the european society of cardiology endorsed by the indian academy of echocardiography. Eur Heart J Cardiovasc Imaging 2017; 18:1090-1121. | | [53] | Amaki M, Savino J, Ain DL, Sanz J, Pedrizzetti G, Kulkarni H, et al. Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy. Circ Cardiovasc Imaging 2014; 7:819-827. | | [54] | Lu S, Ren W, Ma C, Zhang J, Yang J, Xiao Y, et al. The differentiation between constrictive pericarditis and restrictive cardiomyopathy using regional left atrial 2d strain parameters. Chinese J Ultrasound Med 2016, 32: 140-142. | | [55] | Mahmoud A, Bansal M, Sengupta PP. New cardiac imaging algorithms to diagnose constrictive pericard1t1s versus restnct1ve cardiomyopathy. Curr Cardiol Rep 2017, 19: 43. | | [56] | Echocardiography Group, Chinese Society of Ultrasound Medicine, Chinese Medical Association. The consensus of chinese physician on cardiovascular contrast enhanced ultrasound. Chin J Med Ultrasound (Electronic Edition) 2015, 12: 667-680. | | [57] | Tendler A, Helmke S, Teruya S, Alvarez J, Maurer MS. The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis. Amyloid 2015; 22:61-66. | | [58] | Schiano-Lomoriello V, Galderisi M, Mele D, Esposito R, Cerciello G, Buonauro A, et al. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study. Echocardiography 2016; 33:1335-1343. | | [59] | Stricagnoli M, Cameli M, Incampo E, Lunghetti S, Mondillo S. Speckle tracking echocardiography in cardiac amyloidosis. Heart Fail Rev 2019; 24:701-707. | | [60] | Beaton A, Mocumbi AO. Diagnosis and management of endomyocardial fibrosis. Cardiol Clin 2017; 35:87-98. | | [61] | Huang P, Rao L. Ultrasonographic differential diagnosis of constrictive pericarditis and restrictive cardiomyopathy. Chinese J Ultrasonography 2007, 16:727-728. | | [62] | Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/ dysplasia: clinical impact of molecular genetic studies. Circulation 2006, 113: 1634-1637. | | [63] | Zaidi A, Knight DS, Augustine DX, Harkness A, Oxborough D, Pearce K, et al. Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography. Echo Res Pract 2020 ; 7: G19-G41. | | [64] | Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the european association of, cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2016, 17 :412. | | [65] | Echocardiography Group, Chinese Society of Ultrasound Medicine, Chinese Medical Association. Guidelines for measurement of echocardiography in Chinese adults. Chin J Med Ultrasound 2016, 25: 645-666. | | [66] | Liu WX, Zhao Y, Xue C, Han JC, Hao XY, He YH. Echocardiographic features of arrhythmogenic right ventricular cardiomyopathy:analysis of misdiagnosis and miss diagnosis. Chin J Ultrasonogr 2015, 24: 199-203. | | [67] | Corrado D, Wichter T, Link MS, Hauer RN, Marchlinski FE, Anastasakis A, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Circulation 2015; 132:441-453. | | [68] | Sarvari SI, Haugaa KH, Anfinsen OG, Leren TP, Smiseth OA, Kongsgaard E, et al. Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur Heart J 2011; 32:1089-1096. | | [69] | Saberniak J, Leren IS, Haland TF, Beitnes JO, Hopp E, Borgquist R, et al. Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia. Eur Heart J Cardiovasc Imaging 2017; 18:62-69. | | [70] | Kjaergaard J, Petersen CL, Kjaer A, Schaadt BK, Oh JK, Hassager C. Evaluation of right ventricular volume and function by 2D and 3D echocardiography compared to MRI. Eur J Echocardiogr 2006; 7:430-438. | | [71] | Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2015; 16:233-270. | | [72] | Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr 2010; 23:685-713; quiz 786-788. | | [73] | Porter TR, Mulvagh SL, Abdelmoneim SS, Becher H, Belcik JT, Bierig M, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 american society of echocardiography guidelines update. J Am Soc Echocardiogr 2018; 31:241-274. | | [74] | Haugaa KH, Basso C, Badano LP, Bucciarelli-Ducci C, Cardim N, Gaemperli O, et al. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2017; 18:237-253. | | [75] | Towbin JA, Lorts A, Jefferies JL. Left ventricular noncompaction cardiomyopathy. Lancet 2015, 386: 813-825. | | [76] | Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J 2017; 38:3449-3460. | | [77] | Asfalou I, Boulaamayl S, Raissouni M, Mouine N, Sabry M, Kheyi J, et al. Left ventricular noncompaction-a rare form of cardiomyopathy: revelation modes and predictors of mortality in adults through 23 cases. J Saudi Heart Assoc 2017; 29:102-109. | | [78] | Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001; 86:666-671. | | [79] | Finsterer J, Stoll berger C, Towbin JA. Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors. Nat Rev Cardiol 2017, 14: 224-237. | | [80] | Paterick TE, Umland MM, Jan MF, Ammar KA, Kramer C, Khandheria BK, et al. Left ventricular noncompaction: a 25-year odyssey. J Am Soc Echocardiogr 2012; 25:363-375. | | [81] | Jacquier A, Thuny F, Jop B, Giorgi R, Cohen F, Gaubert JY, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 2010; 31:1098-1104. | | [82] | Zhang M, Zhang Y. Ultrasound diagnosis of poor myocardial densification: report of 2 cases. Chin J cardiovascular med 2002, 7:449. | | [83] | Chen SJ, Zhang ZL, Chen M, Dong PS, Yang XM, Wang K, et al. Echocardiographic standardized myocardial segmentation features in patients with left ventricular noncompaction. Chin J Cardiol 2010, 38; 402-405. | | [84] | Eidem BW. Noninvasive evaluation of left ventricular noncompaction: what's new in 2009? Pediatr Cardiol 2009, 30: 682-689. | | [85] | van Dalen BM, Caliskan K, Soliman OI, Nemes A, Vletter WB, Ten Cate FJ, et al. Left ventricular solid body rotation in non-compaction cardiomyopathy: a potential new objective and quantitative functional diagnostic criterion? Eur J Heart Fail 2008; 10:1088-1093. | | [86] | Kalapos A, Domsik P, Forster T, Nemes A. Left ventricular strain reduction is not confined to the noncompacted segments in noncompaction cardiomyopathy-insights from the three-dimensional speckle tracking echocardiographic MAGYAR-path study. Echocardiography 2014; 31:638-643. | | [87] | Sabatino J, Di Salvo G, Krupickova S, Fraisse A, Prota C, Bucciarelli V, et al. Left ventricular twist mechanics to identify left ventricular noncompaction in childhood. Circ Cardiovasc Imaging 2019; 12: e007805. | | [88] | Niemann M, Liu D, Hu K, Cikes M, Beer M, Herrmann S, et al. Echocardiographic quantification of regional deformation helps to distinguish isolated left ventricular non-compaction from dilated cardiomyopathy. Eur J Heart Fail 2012; 14:155-161. | | [89] | Tian M, Zheng M, Ma H, Niu Y, Zhang Y, Xu P. Differentiation of patients with two-dimensional echocardiography false positive non-compaction of ventricular myocardium by contrast echocardiography. Rev Cardiovasc Med 2019; 20:41-46. | | [90] | Lampropoulos KM, Dounis VG, Aggeli C, Iliopoulos TA, Stefanadis C. Contrast echocardiography: contribution to diagnosis of left ventricular non-compaction cardiomyopathy. Hellenic J Cardiol 2011; 52:265-272. | | [91] | Liu XW, Wu YF, Li YD, Sun LL, Jiang W. Value of left ventricular contrast echocardiography in diagnosis of left ventricular myocardium noncompaction. Chin J Ultrasonogr 2011, 20: 201-204. | | [92] | Baker GH, Pereira NL, Hlavacek AM, Chessa K, Shirali G. Transthoracic real-time three-dimensional echocardiography in the diagnosis and description of noncompaction of ventricular myocardium. Echocardiography 2006; 23:490-494. | | [93] | Caselli S, Autore C, Serdoz A, Santini D, Musumeci MB, Pelliccia A, et al. Three-dimensional echocardiographic characterization of patients with left ventricular noncompaction. J Am Soc Echocardiogr 2012; 25:203-239. | | [94] | Zhao J, Hu DY, Guo JH, Zhang FF, Lu WJ, Huang ZW, et al. Assessment of left ventricular systolic synchronicity by quantitative tissue velocity imaging in patients with left ventricular noncompaction. Chin J Cardiol 2010, 38: 398-401. | | [95] | Towbin JA, Lorts A, Jefferies JL. Left ventricular noncompaction cardiomyopa thy. Lancet 2015, 386: 813-825. | | [96] | Yu JC, Zhao SH, Jiang SL, Wang LM, Wang ZF, Lu MJ, et al. Comparison of clinical and MRI features between dilated cardiomyopathy and left ventricular noncompaction. Chin J Cardiol 2010, 38: 392-397. | | [97] | Gati S, Chandra N, Bennett RL, Reed M, Kervio G, Panoulas VF, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart 2013; 99: 401-408. |
|
Advanced Ultrasound in Diagnosis and Therapy (AUDT)
is licensed under a Creative Commons Attribution 4.0 International License.